Works matching DE "APATINIB"

Results: 260

Apatinib Mesylate Inhibits Cell Proliferation and the Metastasis of Esophageal Squamous Cell Carcinoma Through ERK/ELK-1/Snail Pathway.

Published in:

Cell Biochemistry & Biophysics, 2025, v. 83, n. 2, p. 2201, doi. 10.1007/s12013-024-01631-z

By:

Feng, Xiang;
Xu, Di;
Xing, Zhuqin;
Zhang, Qian

Publication type:

Article

Safety and efficacy of apatinib in combination treatment versus apatinib as second-line treatment for advanced gastric cancer.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1587069

By:

Han, Zhang;
Yuanzeng, Zhu;
Gang, Wu;
Peichun, Sun

Publication type:

Article

ملاتونین و آپاتینیب، عوامل کاندید در جهت درمان سرطان از طریق تشکیل ساختارهای شبه عروقی در سرطان یک مطالعه مروری.

Published in:

Journal of Mazandaran University of Medical Sciences (JMUMS), 2025, v. 35, n. 244, p. 194

By:

نازیلا فتحی معرو;
محسن رشیدی

Publication type:

Article

Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14207-8

By:

Wu, Shusheng;
Luo, Huiqin;
Chen, Wenju;
Liu, Xudong;
Li, Huimin;
Li, Mengge;
Ke, Lihong;
Niu, Jiayu;
Hu, Bing;
Xu, Huijun;
Wang, Gang;
Yan, Ying;
Cao, Lulu;
Hu, Xiaoxiu;
Li, Chenghui;
He, Yifu

Publication type:

Article

A gelable polymer loaded with curcumin and apatinib absorbed in gelatin sponge delays postoperative residual tumor growth.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-97732-7

By:

Meng, Zhuo-Nan;
Chen, Jian-Yuan;
Yu, Chong;
Zheng, Ai-hong;
Reddy, O. Sreekanth;
Liu, Kai-Yan;
Su, Yong-Rui;
Zhang, Shi-Tai;
Wang, Yin-Shuang;
Gu, Hang-Yu;
Wang, Fu-Wei;
Xu, Song-Cheng;
Sun, Li-Tao;
Chen, Bing-Chen;
Lai, Wing-Fu;
Wu, Guo-Qing;
Zhang, Da-Hong

Publication type:

Article

Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14250-5

By:

Yalikun, Kugeluke;
Li, Zhongchao;
Zhang, Jianxin;
Chang, Zhibin;
Li, Mingming;
Sun, Zhicheng;
Liu, Zhaogang;
Yang, Yue;
Xu, Lei;
Li, Lei;
Zhang, Chengsheng;
Sun, Pengfei;
Zhong, Jingtao;
Cui, Kai;
Shi, Xuetao;
Zhang, Bo;
Zhao, Lei

Publication type:

Article

Effect and Safety of Apatinib as Neoadjuvant Therapy in Locally Advanced Differentiated Thyroid Cancer: A Phase 2 Trial.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 9, p. 1, doi. 10.1210/jendso/bvae132

By:

Qian, Kai;
Wang, Yunjun;
An, Ning;
Liu, Chunhao;
Guo, Kai;
Yang, Lingyi;
Wang, Jun;
Li, Xiaoyi;
Wang, Zhuoying

Publication type:

Article

CURATIVE EFFECT EVALUATION OF INTRAPERITONEAL HYPERTHERMIC PERFUSION CHEMOTHERAPY COMBINED WITH APATINIB FOR MALIGNANT ASCITES.

Published in:

Farmacia, 2022, v. 70, n. 3, p. 491, doi. 10.31925/farmacia.2022.3.14

By:

LI-PING LIU;
XIAO-FENG LI;
QING CHANG;
YONG-JUAN WU;
KAI LIU;
YA-PING JIN;
JUN WANG

Publication type:

Article

Efficacy and safety of Jianpi Bushen Jiedu formula combined with apatinib and S-1 in the treatment of metastatic colorectal cancer.

Published in:

Journal of Beijing University of Traditional Chinese Medicine, 2022, n. 5, p. 438, doi. 10.3969/j.issn.1006-2157.2022.05.005

By:

CHEN Yue;
JIANG Haijun;
XU Yuying;
WANG Lei;
ZHAI Jiawei;
ZHANG Tong;
YANG Yufei

Publication type:

Article

IL-17 predicts the effect of TACE combined with apatinib in hepatocellular carcinoma.

Published in:

Clinical Hemorheology & Microcirculation, 2021, v. 77, n. 1, p. 37, doi. 10.3233/CH-200857

By:

Wu, Yongjuan;
Cheng, Guangyuan;
Chen, Hui;
Wang, Jingzhong;
Wang, Jiangtao;
Wang, Wanbi

Publication type:

Article

Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA.

Published in:

Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 877, doi. 10.20892/j.issn.2095-3941.2020.0418

By:

Anjie Zhu;
Peng Yuan;
Nanlin Hu;
Mingzhou Li;
Wenmiao Wang;
Xue Wang;
Jian Yue;
Jiayu Wang;
Yang Luo;
Fei Ma;
Pin Zhang;
Qing Li;
Binghe Xu;
Shanbo Cao;
Giuseppe Lippi;
Yoichi Naito;
Osman, Mohammed A.;
Marta, Gustavo N.;
Franceschini, Gianluca;
Orlandi, Armando

Publication type:

Article

Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57874-6

By:

Wang, Hankang;
Gao, Congcong;
Li, Xiaodong;
Chen, Feng;
Li, Guijie

Publication type:

Article

Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective study.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40030-x

By:

Chen, Dongbo;
Wang, Yichun;
Chen, Xiangxun;
Kang, Mei;
Zhu, Liyang

Publication type:

Article

Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1115422

By:

Fangfang Gao;
Jingtai Li;
Haoran Liao;
Pingming Fan;
Minjian Wang;
Yu Liu;
Linwei Ding;
Guankui Du

Publication type:

Article

Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1101063

By:

Dan Peng;
Yongqing Cai;
Geng Chen;
Min Hou;
Xiaofeng Luo;
Zhuoma Dongzhi;
Hongjun Xie;
Yao Liu

Publication type:

Article

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 3, p. 743, doi. 10.4143/crt.2023.980

By:

Yoon-Koo Kang;
Min-Hee Ryu;
Yong Sang Hong;
Chang-Min Choi;
Tae Won Kim;
Baek-Yeol Ryoo;
Jeong Eun Kim;
Weis, John R.;
Kingsford, Rachel;
Cheol Hee Park;
Seong Jang;
McGinn, Arlo;
Werner, Theresa L.;
Sharma, Sunil

Publication type:

Article

Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45126-0

By:

Liang, Hu;
Jiang, Yao-Fei;
Liu, Guo-Ying;
Wang, Lin;
Wang, Jian-Wei;
Lu, Nian;
Xia, Wei-Xiong;
Ke, Liang-Ru;
Ye, Yan-Fang;
Duan, Jin-Lin;
Bei, Wei-Xin;
Dong, Shu-Hui;
Li, Wang-Zhong;
Liu, Li-Ting;
Zhao, Chong;
Xie, Changqing;
Xiang, Yan-Qun

Publication type:

Article

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x

By:

Yuan, Li;
Jia, Guo-Dong;
Lv, Xiao-Fei;
Xie, Si-Yi;
Guo, Shan-Shan;
Lin, Da-Feng;
Liu, Li-Ting;
Luo, Dong-Hua;
Li, Yi-Fu;
Deng, Shen-Wen;
Guo, Ling;
Zeng, Mu-Sheng;
Cai, Xiu-Yu;
Liu, Sai-Lan;
Sun, Xue-Song;
Li, Xiao-Yun;
Li, Su-Chen;
Chen, Qiu-Yan;
Tang, Lin-Quan;
Mai, Hai-Qiang

Publication type:

Article

Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.

Published in:

Emergency Medicine International, 2022, p. 1, doi. 10.1155/2022/6293816

By:

Zhan, Dechao;
Chen, Zihong;
Yang, Donghong;
Wen, Jiyu;
Liu, Wanwan

Publication type:

Article

"Highly Exposed Chinese Herbal Medicine" Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study.

Published in:

Dose-Response, 2021, v. 19, n. 4, p. 1, doi. 10.1177/15593258211055016

By:

Wang, Mingqi;
Jiang, Haili;
Zhang, Mei;
Chen, Yang;
Wang, Ting;
Li, Ping

Publication type:

Article

Efficacy and survival analysis of apatinib combined with capecitabine chemotherapy for second-line treatment of advanced esophageal cancer.

Published in:

Indian Journal of Chemical Technology, 2022, v. 29, n. 6, p. 793, doi. 10.56042/ijct.v29i6.67385

By:

Jinfa Xu;
Qing Cai;
Xiufang Zhang;
Jianhua Zhang

Publication type:

Article

Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis.

Published in:

World Journal of Surgical Oncology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12957-023-03055-0

By:

Ma, Yongli;
Li, Jinghui;
Wen, Liang;
Zhang, Guosheng;
Yao, Xueqing

Publication type:

Article

Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study.

Published in:

World Journal of Surgical Oncology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12957-023-02973-3

By:

Deng, Ya-Ya;
Jiang, Ding-Yi;
Zhu, Peng-Fei;
Lu, Hongrui;
Liu, Qian;
Zhang, Xinyue;
Pan, Shuang-Yue;
Chen, Zhe-Ling;
Yang, Liu

Publication type:

Article

Short-term efficacy and safety of camrelizumab-based treatment in refractory or metastatic esophageal squamous cell carcinoma.

Published in:

Indian Journal of Cancer, 2024, v. 61, n. 4, p. 710, doi. 10.4103/ijc.IJC_1275_20

By:

Yuan, Yuan;
Meng, Qingliang;
Li, Xiaowu;
Zhang, Youwei;
Sun, Sanyuan

Publication type:

Article

The clinical efficacy and safety of TACE combined with apatinib for advanced hepatocellular carcinoma: A propensity score matching analysis.

Published in:

Indian Journal of Cancer, 2024, v. 61, n. 2, p. 390, doi. 10.4103/ijc.IJC_967_20

By:

Cheng Chen;
Xiaoting Duan;
Yanfeng Shen;
Guiying Li

Publication type:

Article

Efficacy and safety of apatinib for elderly patients with previously treated extensive‑stage colorectal cancer patients and the prognostic significance of common adverse reactions.

Published in:

Indian Journal of Cancer, 2024, v. 61, n. 2, p. 317, doi. 10.4103/ijc.IJC_1368_20

By:

Yongjun Yu;
Yuwei Li;
Chen Xu;
Weihua Zhang

Publication type:

Article

Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients.

Published in:

Indian Journal of Cancer, 2023, v. 60, n. 4, p. 562, doi. 10.4103/ijc.ijc_907_21

By:

Jingwei Yan;
Yumei Sun;
Daguang Fan;
Wei Mu

Publication type:

Article

EGCG enhances antitumor effect of apatinib in nonsmall cell lung cancer by targeting VEGF signaling to inhibit glycolysis.

Published in:

Drug Development Research, 2024, v. 85, n. 7, p. 1, doi. 10.1002/ddr.22239

By:

Zhou, Yue;
Qin, Liqing;
Li, Chengpeng;
Zhu, Danxue;
Liu, Bo

Publication type:

Article

Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 379, doi. 10.1002/ddr.21867

By:

Bei, Yanping;
Chen, Xue;
Xu, Quan;
Lv, Jiaming;
Hu, Jing;
Yang, Shaohui

Publication type:

Article

Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer.

Published in:

Pathology & Oncology Research, 2023, p. 1, doi. 10.3389/pore.2023.1611114

By:

Guohu Han;
Changchun Sun;
Lihua Cui;
Yufeng Huang;
Lijiang Yu;
Shenzha Liu;
Min Tao

Publication type:

Article

A Comparison Study on Polysaccharides Extracted from Atractylodes chinensis (DC.) Koidz. Using Different Methods: Structural Characterization and Anti-SGC-7901 Effect of Combination with Apatinib.

Published in:

Molecules, 2022, v. 27, n. 15, p. 4727, doi. 10.3390/molecules27154727

By:

Zhou, Pingfan;
Xiao, Wanwan;
Wang, Xiaoshuang;
Wu, Yayun;
Zhao, Ruizhi;
Wang, Yan

Publication type:

Article

Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1143578

By:

Kunpeng Wu;
Yahua Li;
Zongming Li;
Zihe Zhou;
Xiaoyong Ge;
Yifan Li;
Xinwei Han;
Peng Chen;
Kewei Ren

Publication type:

Article

Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1203980

By:

Zhiyuan Qiu;
Rong Qin;
Ziyi Zhang;
Ting Zhang;
Zhao Zhang;
Chunyue Qiao;
Yan Xi;
Guangyu Tian;
Yan Wang

Publication type:

Article

Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1076469

By:

Ruyan Zhang;
Yifei Chen;
Xiaoran Liu;
Xinyu Gui;
Anjie Zhu;
Hanfang Jiang;
Bin Shao;
Xu Liang;
Ying Yan;
Jiayang Zhang;
Guohong Song;
Huiping Li

Publication type:

Article

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1148131

By:

Donghan Xu;
Yehao Luo;
Peng Wang;
Jiaxin Li;
Linrui Ma;
Jie Huang;
Hao Zhang;
Xiaoman Yang;
Liqi Li;
Yuhong Zheng;
Gang Fang;
Peiyu Yan

Publication type:

Article

Transarterial chemoembolization with or without multikinase inhibitors for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1139025

By:

Han Dong;
Dongfang Ge;
Biao Qu;
Ping Zhu;
Qibiao Wu;
Tianyun Wang;
Jue Wang;
Zheng Li

Publication type:

Article

Efficacy and feasibility of Apatinib and S-1 as a novel oral induction therapy in locally advanced head and neck squamous cell carcinoma: an exploratory phase 2 open-label, single-arm trial.

Published in:

Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1072538

By:

Wen Jiang;
Rongrong Li;
Lin Zhang;
Shengjin Dou;
Lulu Ye;
Ziyang Shao;
Sicheng Wu;
Minjun Dong;
Jiang Li;
Guopei Zhu

Publication type:

Article

Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1072943

By:

Jinglei Qu;
Xin He;
Ying Luo;
Ping Yu;
Ying Chen;
Jing Liu;
Xin Wang;
Chang Wang;
Tingting Liang;
Yuxian Bai;
Yu Han;
Li Man;
Chuanchun Leng;
Caiyun Zhou;
Lijie He;
Yunpeng Liu;
Xiujuan Qu

Publication type:

Article

Acute inflammatory reaction during anti-angiogenesis therapy combined with immunotherapy as a possible indicator of the therapeutic effect: Three case reports and literature review.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1072480

By:

Yihui Lei;
Li Lin;
Shuyu Cheng;
Qiming Shao;
Chenchun Ding;
Renjie Zuo;
Weiping Chen;
Quan Liao;
Guoyan Liu

Publication type:

Article

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136366

By:

Qing Yang;
Gengyu Li;
Xiaoqiu Wu;
Haiying Lin;
Wanrui Wu;
Xiangpang Xie;
Yu Zhu;
Wei Cai;
Changsheng Shi;
Shengye Zhuo

Publication type:

Article

Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1118820

By:

Chan Zhang;
Yaoxian Xiang;
Jing Wang;
Dong Yan

Publication type:

Article

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1147849

By:

Passardi, Alessandro;
Bittoni, Alessandro;
Zhigang Bai;
Zhongtao Zhang;
Sier, Cornelis;
Yulong He;
Shahini, Endrit;
Solimando, Antonio Giovanni

Publication type:

Article

The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1030798

By:

Jijin Wang;
Di Huang;
Wenjing Yang;
Qingxu Song;
Yibin Jia;
Pengxiang Chen;
Yufeng Cheng

Publication type:

Article

Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1057560

By:

Di Zhu;
Kun Ma;
Wei Yang;
Hai-Feng Zhou;
Qi Shi;
Jian-Wu Ren;
Yu-Guan Xie;
Sheng Liu;
Hai-Bin Shi;
Wei-Zhong Zhou

Publication type:

Article

Activity and safety of apatinib monotherapy or apatinib combined with chemotherapy for patients with metastatic or unresectable osteosarcoma over the age of 40 years: A retrospective analysis.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1031787

By:

Taojun Gong;
Qi Huang;
Fan Tang;
Yitian Wang;
Zhuangzhuang Li;
Yi Luo;
Li Min;
Yong Zhou;
Chongqi Tu

Publication type:

Article

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.952494

By:

Qingli Cui;
Yuefeng Mao;
Daoyuan Wu;
Yanhui Hu;
Dongyang Ma;
LiHan Zhang;
Huaimin Liu

Publication type:

Article

Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.876899

By:

Yonggang Wang;
Chang Wang;
Yanqiao Zhang;
Jiqing Hao;
Nong Yang;
Jvfeng Wang;
Min Peng;
Tianshu Liu;
Guifang Zhang;
Xianbao Zhan;
Shan Zeng;
Yifan Zhang;
Yong Gao;
Yang Yao

Publication type:

Article

Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.961394

By:

Wei-Li Xia;
Xiao-Hui Zhao;
Yuan-Guo;
Guang-Shao Cao;
Gang Wu;
Wei-Jun Fan;
Quan-Jun Yao;
Shi-Jun Xu;
Chen-Yang Guo;
Hong-Tao Hu;
Hai-Liang Li

Publication type:

Article

Evaluation of the efficacy of transcatheter arterial embolization combined with apatinib on rabbit VX2 liver tumors by intravoxel incoherent motion diffusion-weighted MR imaging.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951587

By:

Can Chen;
Xiao Liu;
Lingling Deng;
Yunjie Liao;
Sheng Liu;
Pengzhi Hu;
Qi Liang

Publication type:

Article

Efficacy and safety of apatinib monotherapy for patients with advanced breast cancer: a systematic review and meta-analysis.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.940171

By:

Xuchen Huang;
Xuhua Hu;
Tongbo Yi

Publication type:

Article